AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT07512206
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- OPCI Core Laboratories LLC
- Registry
-
NCT07512206
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07512206. Allocation not applicable; no masking; primary purpose treatment. Start 2026-04-01 (anticipated); primary completion 2026-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease
- Acronym
- AERO CAD
- Condition
- Coronary Calcification
- Condition
- Coronary Calcified Disease
- Condition
- Coronary Calcified Nodules
- Intervention (Device)
- Shockwave C2 Aero Coronary IVL System
- Lead sponsor
- OPCI Core Laboratories LLC
Record details
- Record id
cardio:ct-nct07512206- Content hash
71922765d5a08d0fd592d9cc4ceca893f46bfaf878605328feea9003a2c3b450